Product Information
DIPYRIDAMOLE 50 MG TABLET is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $0.3573 per EA under NDC 00115107101. Its NADAC has been published 440 times since Nov 28, 2013.
FDA first approved this application on Jul 18, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
00115107101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DIPYRIDAMOLEApproval Type
Generic (ANDA)
FDA Application
ANDA040782FDA Approved
7/18/2007
TE Code
AB
On Market Since
8/30/2021
Pharmacological Classes
Price Statistics
The NADAC for DIPYRIDAMOLE 50 MG TABLET has been published 440 times since Nov 28, 2013, and over the history we have for it it has risen 98.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3573 per EA |
|---|---|
| All-time high | $1.3510 (Jun 15, 2022) |
| All-time low | $0.1247 (Feb 22, 2017) |
| 52-week high | $0.3623 |
| 52-week low | $0.2736 |
| Median price | $0.3045 |
| Average price | $0.4615 |
| Largest weekly change | +170.5% (Apr 19, 2017) |
| Weeks tracked | 440 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the DIPYRIDAMOLE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals of New York LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
DIPYRIDAMOLE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Platelet Aggregation Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DIPYRIDAMOLE 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DIPYRIDAMOLE 50 MG TABLET, manufactured by Amneal Pharmaceuticals of New York LLC, is $0.3573 per EA (NDC 00115107101), effective Sep 30, 2026.
How has the price of DIPYRIDAMOLE 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for DIPYRIDAMOLE 50 MG TABLET has risen 98.7%. It has been tracked across 440 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DIPYRIDAMOLE 50 MG TABLET?
Since Nov 28, 2013, the NADAC for DIPYRIDAMOLE 50 MG TABLET has ranged from a low of $0.1247 (Feb 22, 2017) to a high of $1.3510 (Jun 15, 2022), with a median of $0.3045 per EA.
Are there cheaper alternatives to DIPYRIDAMOLE 50 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of DIPYRIDAMOLE 50 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DIPYRIDAMOLE 50 MG TABLET?
DIPYRIDAMOLE 50 MG TABLET (NDC 00115107101) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.